Opdivo works by targeting a protein called PD-1 (Programmed Death-1) found on the surface of T-cells, which are a type of white blood cell involved in the immune response. Cancer cells often exploit this protein to evade immune detection. By blocking PD-1, Opdivo enhances the bodyâs ability to detect and destroy cancer cells.